Product Overview
[Drug Name]
Generic Name: Colloidal Bismuth Pectin Capsules
Trade Name: JiuZuo Colloidal Bismuth Pectin Capsules 55mg*24 Capsules
Pinyin Code: JiuZuo JiaoTiJiuShiSuanZuoJiaoNang 55mg*24Li
[Main Ingredients]
The main ingredient of this product is colloidal bismuth tartrate.
[Properties]
This product is a capsule containing a light yellow powder.
[Indications/Main Functions]
Treatment of peptic ulcers, particularly Helicobacter pylori-associated ulcers. It can also be used for chronic colitis, diarrhea caused by ulcerative colitis, and chronic superficial and atrophic gastritis.
[Specifications]
55mg*24 Capsules (JiuZuo)
[Dosage and Administration]
Oral administration. 165mg (3 capsules) per dose, 4 times daily, one hour before each of the three meals and at bedtime.
[Adverse Reactions]
Nausea, constipation, and other gastrointestinal symptoms may occur occasionally.
[Contraindications]
This product is contraindicated in patients with allergies or renal insufficiency.
[Drug Interactions]
This product should not be taken with antacids, milk, or H2 receptor blockers, as this may reduce its effectiveness.
[Precautions]
1. Dark brown, dull stools without other discomfort during medication are normal. The color should return to normal 1-2 days after discontinuation. 2. This product is not suitable for long-term use in high doses.
[Overdose]
Long-term use of high doses of this product may cause nausea, manifested by dark brown discoloration of the skin. Discontinue use immediately and seek appropriate treatment.
[Pharmacology and Toxicology]
This product is a gastrointestinal mucosal protective agent. It forms a protective layer on the surface of the gastrointestinal mucosa, promoting ulcer healing and inflammation relief. It also stimulates mucus secretion by epidermal cells on the mucosa, enhancing mucosal protection and killing Helicobacter pylori. Animal experiments have shown that this product can reduce the number of ulcers in experimental ulcerative colitis rabbits, shrink the diameter of ulcers, and reduce the frequency of bowel movements and loose stools in experimental ulcerative colitis rabbits and rats.
